I’m more interested in the current TCA Receivership. The only reason it seems like my agenda is negative is because the nature of the situation does negatively affect the company. For me, it’s just an extremely rare and unique situation for an OTC issuer.
TCA’s security interests in most, if not all, of PACV’s assets gives the court access to information that Shannon may or may not disclose in SEC filings. It’s definitely going to test her character as well as her business acumen.
I suppose Hart’s history is relevant to a certain extent, but he has very little influence over what’s ultimately going to have a significant impact on the company.
$PACV